Literature DB >> 6608333

Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study.

T Farkas, A P Wolf, J Jaeger, J D Brodie, D R Christman, J S Fowler.   

Abstract

Thirteen diagnosed schizophrenics and 11 normal controls were studied with a method using the PETT III positron emission tomograph (PET) and fluorodeoxyglucose labeled with fluorine 18. Each subject also had a computed tomographic (CT) scan. For each subject, two brain levels, one through the basal ganglia and one through the semioval center, were analyzed for the mean regional metabolic glucose rate. Specifically, relationships between frontal and posterior regions were evaluated. The CT scans of matching levels were superimposed on the functional PET images to provide anatomic criteria for region of interest selection. While no whole-slice metabolic differences were apparent between groups, schizophrenics had significantly lower activity in the frontal lobes, relative to posterior regions. The medicated and drug-free groups did not differ from one another in these regards. Trait v state dependency of the phenomenon was analyzed, and several technological limitations were considered.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6608333     DOI: 10.1001/archpsyc.1984.01790140083010

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  18 in total

Review 1.  Neuropsychiatric rehabilitation for persistent mental illness.

Authors:  J Jaeger; E Douglas
Journal:  Psychiatr Q       Date:  1992

Review 2.  Negative symptoms: psychopathological models.

Authors:  J Ananth; A Djenderdjian; P Shamasunder; J Costa; J Herrera; J Sramek
Journal:  J Psychiatry Neurosci       Date:  1991-03       Impact factor: 6.186

Review 3.  Structural and functional brain imaging in schizophrenia.

Authors:  J M Cleghorn; R B Zipursky; S J List
Journal:  J Psychiatry Neurosci       Date:  1991-07       Impact factor: 6.186

Review 4.  Essential aspects of the research problem in schizophrenia.

Authors:  S R Hirsch
Journal:  J R Soc Med       Date:  1988-12       Impact factor: 5.344

5.  Disruption of Akt signaling decreases dopamine sensitivity in modulation of inhibitory synaptic transmission in rat prefrontal cortex.

Authors:  Yan-Chun Li; Sha-Sha Yang; Wen-Jun Gao
Journal:  Neuropharmacology       Date:  2016-05-06       Impact factor: 5.250

Review 6.  A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia.

Authors:  Eleanor H Simpson; Christoph Kellendonk; Eric Kandel
Journal:  Neuron       Date:  2010-03-11       Impact factor: 17.173

7.  Brain imaging: evoked potential, quantitative EEG and SPECT abnormalities in schizophrenia.

Authors:  K G Sieg; D A Willsie; D F Preston; G R Gaffney
Journal:  J Psychiatry Neurosci       Date:  1991-03       Impact factor: 6.186

8.  Effects of haloperidol and SCH 23390 on acoustic startle in animals depleted of dopamine as neonates: implications for neuropsychiatric syndromes.

Authors:  S B Schwarzkopf; J P Bruno; T Mitra; J R Ison
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

9.  Left globus pallidus abnormality in never-medicated patients with schizophrenia.

Authors:  T S Early; E M Reiman; M E Raichle; E L Spitznagel
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

10.  Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration.

Authors:  N D Volkow; J D Brodie; A P Wolf; B Angrist; J Russell; R Cancro
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.